A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer....

by Pizzuti Laura, Carpino Armando, Vizza Enrico, Botti Claudio, Perri Pasquale, Filippelli Gianfranco, Sergi Domenico, Giotta Francesco, Colucci Giuseppe, Vici Patrizia, Latorre Agnese, Giannarelli Diana, Lopez Massimo, Di Lauro Luigi
Published 2011-04-01